MEGHAN MCCARTER: Open Payments
NPI 1740622398 · SEAFORD, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$61,270 in 272 payments from 23 companies in 2025. Trend: 2023 $34,953 · 2024 $61,783 · 2025 $61,270
Speaker / faculty: $52,558Food & beverage: $4,611Travel & lodging: $4,002Education: $100
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 127 | $55,005 |
| GENZYME CORPORATION | 3 | $3,516 |
| ABBVIE INC. | 48 | $786 |
| UCB, Inc. | 24 | $312 |
| Janssen Biotech, Inc. | 9 | $263 |
| GlaxoSmithKline, LLC. | 11 | $204 |
| Lilly USA, LLC | 8 | $169 |
| Novartis Pharmaceuticals Corporation | 6 | $133 |
| PFIZER INC. | 4 | $118 |
| Fresenius Kabi USA, LLC | 5 | $108 |
Products named: KRYSTEXXA, KEVZARA, SKYRIZI, RINVOQ, Bimzelx, TREMFYA, BENLYSTA, Otezla.
Industry payments across DE — which companies pay providers there.
